A Randomized Phase III Study of Gemcitabine, Dexamethasone, and Cisplatin Versus Dexamethasone, Cytarabine, and Cisplatin as Salvage Chemotherapy Followed by Posttransplantation Rituximab Maintenance Therapy Versus Observation for Treatment of Aggressive B-Cell and T-Cell Non-Hodgkin's Lymphoma
- 1 June 2005
- journal article
- research article
- Published by Elsevier BV in Clinical Lymphoma
- Vol. 6 (1), 56-60
- https://doi.org/10.3816/clm.2005.n.030
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Improving Second-Line Therapy in Aggressive Non-Hodgkin’s LymphomaSeminars in Oncology, 2004
- Future directions in radioimmunotherapy for B-cell lymphomaSeminars in Oncology, 2003
- CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell LymphomaThe New England Journal of Medicine, 2002
- Ifosfamide, Carboplatin, and Etoposide: A Highly Effective Cytoreduction and Peripheral-Blood Progenitor-Cell Mobilization Regimen for Transplant-Eligible Patients With Non-Hodgkin's LymphomaJournal of Clinical Oncology, 1999
- Current Guidelines for the Management of Aggressive Non-Hodgkinʼs LymphomaDrugs, 1997
- Activity of gemcitabine in patients with advanced pancreatic carcinoma: A reviewCancer, 1996
- Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's LymphomaThe New England Journal of Medicine, 1995
- Randomized comparison of MACOP-B with CHOP in patients with intermediate-grade non-Hodgkin's lymphoma. The Australian and New Zealand Lymphoma Group.Journal of Clinical Oncology, 1994
- Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's LymphomaThe New England Journal of Medicine, 1993
- Comparison of a Second-Generation Combination Chemotherapeutic Regimen (m-BACOD) with a Standard Regimen (CHOP) for Advanced Diffuse Non-Hodgkin's LymphomaThe New England Journal of Medicine, 1992